Literature DB >> 8227963

Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret.

L A Blackshaw1, D Grundy.   

Abstract

This study was undertaken to determine the effects of 5-hydroxytryptamine (5-HT) on vagal mucosal afferent endings and how this may relate to their sensitivity to other stimuli. Single afferent fibres with receptive fields in the mucosa of the upper gastrointestinal tract were recorded from the cervical vagus of Urethane anaesthetized ferrets. The selection criteria included failure to respond to luminal distension (i.e., vagal tension receptors were excluded). All fibres tested responded to mucosal stroking. The majority of these (28/32) also responded to close-intrarterially applied 5-HT (10 micrograms) with a brief burst (usually < 15 s) of action potentials, which in 6/6 cases was reduced or abolished by the 5-HT3 receptor antagonist granisetron (0.1-0.5 mg/kg i.v.), as were four responses to cholecystokinin-octapeptide (100-400 pmol close I.A.). The response to 5-HT was shown to be dose-dependent over the dose range 2-75 micrograms on six occasions. Responses to luminal stimuli, which included 150 mM HCl, 1 M NaCl, and mucosal stroking, were not blocked by granisetron although in three fibres, the resting discharge was reduced by the antagonist, suggesting that resting discharge in vagal mucosal afferents may be influenced by endogenously released 5-HT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227963     DOI: 10.1016/0165-1838(93)90360-7

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  43 in total

Review 1.  Visceral perception: sensory transduction in visceral afferents and nutrients.

Authors:  H E Raybould
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  A clinicopathological study of serotonin of sigmoid colon mucosa in association with chronic symptoms in uncomplicated diverticulosis.

Authors:  S Jeyarajah; N Akbar; J Moorhead; A Haji; S Banerjee; S Papagrigoriadis
Journal:  Int J Colorectal Dis       Date:  2012-06-29       Impact factor: 2.571

3.  An in vitro study of the properties of vagal afferent fibres innervating the ferret oesophagus and stomach.

Authors:  A J Page; L A Blackshaw
Journal:  J Physiol       Date:  1998-11-01       Impact factor: 5.182

4.  Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum.

Authors:  K Hillsley; D Grundy
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

Review 5.  The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.

Authors:  Claudio Blasi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

6.  Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat.

Authors:  J X Zhu; X Y Zhu; C Owyang; Y Li
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

7.  Excitation of rat colonic afferent fibres by 5-HT(3) receptors.

Authors:  Gareth A Hicks; Jonathan R Coldwell; Marcus Schindler; Philip A Bland Ward; David Jenkins; Penny A Lynn; Patrick P A Humphrey; L Ashley Blackshaw
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

8.  Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells.

Authors:  Ravinarayan Raghupathi; Michael D Duffield; Leah Zelkas; Adrian Meedeniya; Simon J H Brookes; Tiong Cheng Sia; David A Wattchow; Nick J Spencer; Damien J Keating
Journal:  J Physiol       Date:  2013-10-07       Impact factor: 5.182

9.  Effects of leptin on cat intestinal vagal mechanoreceptors.

Authors:  Stéphanie Gaigé; Anne Abysique; Michel Bouvier
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.